-
Polygodial Workflows for TRPA1 Channel Studies
2026-09-08
Polygodial offers a chemically timed way to interrogate TRPA1 activation, calcium entry, NFAT signaling, and inflammatory outputs in epithelial and neuronal models. This workflow separates rapid channel responses from slower transcriptional effects while providing practical controls for specificity, solvent tolerance, and assay reproducibility.
-
QPRT, P2Y11 Signaling, and Breast Cancer Invasion
2026-09-08
Liu et al. linked elevated quinolinate phosphoribosyltransferase (QPRT) with breast cancer migration and invasion, identifying myosin light-chain phosphorylation as a functional endpoint. Genetic and inhibitor-based experiments implicated P2Y11-associated purinergic signaling and a Rho–ROCK–PLC–MLCK axis, while leaving direct receptor activation and clinical translation unresolved.
-
S-Adenosylmethionine (SAM) in Cell Assays
2026-09-07
This scenario-based guide explains how S-Adenosylmethionine (SAM), SKU B3513, can improve the interpretation of viability, proliferation, cytotoxicity, and methylation experiments. It connects concentration selection, solvent handling, orthogonal readouts, and methionine-cycle biology to recent hepatic stellate cell findings.
-
Amyloid Beta-peptide (25-35) Workflow Guide
2026-09-05
Build a reproducible Aβ25-35 neurotoxicity workflow that separates peptide handling, neuronal injury, oxidative stress, and microglial signaling. This practical guide connects the fragment to amyloid aggregation studies, tau phosphorylation kinase investigation, and the FLOT1–FOSL2–EphA2 axis described in recent Alzheimer’s disease research.
-
Temafloxacin Pharmacokinetics: Findings from a 1991 Review
2026-09-05
The 1991 review integrates oral and intravenous pharmacokinetic data to define temafloxacin absorption, distribution, elimination, and dosing-interval logic. Its key practical findings were greater than 90% oral bioavailability, an approximately 8-hour serum half-life, substantial urinary recovery of unchanged drug, and a need to extend the dosing interval in significant renal impairment.
-
Omeprazole A2845: Research Protocol Guide
2026-09-04
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research and related antiulcer activity studies. It is intended for scientific research workflows only, not for diagnostic, clinical, or therapeutic use, and requires careful DMSO handling because it is insoluble in water and ethanol.
-
From Natural Products to Cryptosporidium Targets
2026-09-04
A translational framework for using the DiscoveryProbe Natural Product Library Plus to connect enzyme-focused screening with cell-based antiparasitic validation, informed by recent Cryptosporidium parvum AdhE research.
-
Redox Intelligence in Hypoxic Tumor Microenvironments
2026-09-03
Hypoxia and immunometabolic competition reshape the tumor microenvironment, but translational insight depends on measuring the redox phenotype that accompanies these changes. This article presents GSH/GSSG profiling as a practical bridge between mechanism, assay strategy, and therapeutic decision-making.
-
DAPI Nuclear Stain Solution: Workflow Guide
2026-09-03
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane integrity. It is suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, but it is not intended for routine imaging of intact live cells.
-
Rifampin and the Next Era of Gene Control
2026-09-02
Rifampin offers a precise bacterial transcriptional perturbation, while a newly reported light-inducible RNA-releasing protein enables reversible translational control in mammalian gene therapy models. Together, these systems illustrate how translational researchers can move from single-molecule mechanism to programmable biological control without confusing distinct experimental domains.
-
Targeted CRISPRi Delivery Improves Metabolic Disease
2026-09-02
Chung and colleagues developed a nonviral, adipocyte-targeted CRISPR interference system that represses Fabp4 in white adipocytes. In obese mice, this strategy reduced obesity-associated inflammation and improved hepatic steatosis and insulin resistance, illustrating how tissue-selective gene regulation can address interconnected metabolic phenotypes.
-
CRTC–CREB Signaling in Proteotoxic Stress
2026-09-01
The reference study identifies CRTC–CREB as a transcriptional sensor that detects proteasome inhibition through ROS and JNK signaling in Drosophila. Its genetic and cell-based experiments connect this response to improved proteostasis, reduced Huntington’s disease-associated aggregation, and protection against age-related protein stress.
-
Matrine, YTHDF1, and Thymoma Stemness
2026-09-01
A 2026 study links Matrine treatment with reduced stemness-associated behavior and increased apoptosis in EL-4-B5 thymoma cells, implicating YTHDF1 and Wnt/β-catenin signaling. The findings provide a useful mechanistic framework for assay development, but the absence of direct m6A measurements, animal experiments, and clinical validation limits causal and translational conclusions.
-
TRPV1, TRPA1, and TSLP in Nasal Epithelium
2026-08-31
The reference study shows that TRPV1 and TRPA1 are functional sensors on nasal epithelial cells, not only on sensory neurons, and links their activation to TSLP production through calcium influx and NFAT nuclear signaling. Its combination of pharmacological stimulation, receptor inhibition, siRNA, calcium chelation, and imaging provides a useful framework for studying epithelial ion-channel control of airway inflammation.
-
Spermine Tetrahydrochloride: Bench Workflows
2026-08-30
Spermine tetrahydrochloride supports three distinct laboratory workflows: protoplast protection, protein crystallization, and ionic polyphosphazene nanoparticle assembly. This practical guide connects concentration selection, charge-driven formulation, assay readouts, and troubleshooting to reproducible bench decisions.